INIS
reduction
100%
risks
64%
cholesterol
47%
blood pressure
41%
density
35%
lipoproteins
35%
range
11%
therapy
11%
testing
5%
patients
5%
interactions
5%
reviews
5%
Biochemistry, Genetics and Molecular Biology
Reduction (Chemistry)
58%
Risk Reduction
41%
Cholesterol
35%
Low-Density Lipoprotein
35%
Blood Pressure
35%
Cholesterol Blood Level
11%
Systolic Blood Pressure
5%
Taxonomy
5%
Medicine and Dentistry
Relative Risk Reduction
41%
Blood Pressure
35%
Low Density Lipoprotein Cholesterol
35%
Cardiovascular Disease
23%
Combination Therapy
11%
Cholesterol
11%
Cardiovascular Risk
11%
Systolic Blood Pressure
5%
Meta-Analysis
5%
Patient
5%
Therapeutic Procedure
5%
Joint
5%
Systematic Review
5%
Pharmacology, Toxicology and Pharmaceutical Science
Low Density Lipoprotein Cholesterol
35%
Randomized Controlled Trial
17%
Cardiovascular Risk
11%
Cholesterol
11%
Placebo
11%